The endocannabinoid system (ECS) is a biological system found in all mammals and helps regulate various physiological processes such as pain, appetite, mood, and immune system responses. The ECS is responsible for maintaining homeostasis, or balance, in the body. Cannabinoids are compounds that interact with the ECS, either internally or from an external source. The body produces Endocannabinoids naturally, while exogenous cannabinoids come from plants like cannabis or hemp. One such exogenous cannabinoid is cannabidiol (CBD). CBD is a non-psychoactive compound that has been shown to have numerous health benefits. It is known for its anti-inflammatory, analgesic, and anti-anxiety properties. CBD is extracted from the cannabis plant and is commonly used to treat chronic pain, anxiety, and epilepsy.
Medical cannabis, on the other hand, contains an array of cannabinoids, including THC, the psychoactive compound. THC has medical benefits as well, including pain relief, appetite stimulation, and reduced nausea. Medical cannabis can treat conditions such as cancer, multiple sclerosis, and Crohn’s disease.
Though CBD and medical cannabis have been met with controversy, research shows that they offer numerous potential benefits, especially for those suffering from chronic conditions. The FDA has approved the use of CBD in the treatment of epilepsy.
In conclusion, the ECS plays a vital role in maintaining homeostasis in the body. CBD and medical cannabis are exogenous cannabinoids that interact with the ECS and have potential therapeutic benefits. These compounds offer hope for those suffering from chronic conditions.
About Renee Harper
Renee Harper, RN, owner and founder of Green Hope Wellness, is passionate about educating people so they can make educated decisions concerning health and wellness. Go to greenhopewellness.com to sign up for free educational classes or schedule an in-person or virtual appointment for a medical cannabis card today! We have helped thousands of Oklahomans find hope when traditional healthcare failed them.
Article originally published in MOORE MONTHLY | SEPTEMBER 2023
